RecruitingPhase 2NCT03624244
Evaluation of Clinical Impact of Interruption VS Maintenance of AI in Patients With Locally Advanced/ Metastatic Low Grade Endometrial Stromal Sarcoma (LGESS)
Studying Endometrial stromal sarcoma
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Centre Leon Berard
- Principal Investigator
- Isabelle RAY-COQUARD, MD PhD, MD,PHDCentre Leon Berard
- Intervention
- Aromatase Inhibitors(drug)
- Enrollment
- 40 target
- Eligibility
- 18 years · FEMALE
- Timeline
- 2019 – 2031
Study locations (21)
- CHU Besançon, Besançon, France
- Insitut Bergonié, Bordeaux, France
- Centre François Baclesse, Caen, France
- Centre Jean Perrin, Clermont-Ferrand, France
- Centre Oscar Lambret, Lille, France
- CHU Dupuytren, Limoges, France
- Centre Léon Bérard, Lyon, France
- Hopital La Timone, Marseille, France
- Institut Paoli Calmette, Marseille, France
- Institut de Cancérologie de Montpellier, Montpellier, France
- Centre Antoine Lacassagne, Nice, France
- Hopital Pitié Salpétrière, Paris, France
- AP-HP Hopîtal Cochin, Paris, France
- Insitut Curie, Paris, France
- Institut Godinot, Reims, France
- +6 more locations on ClinicalTrials.gov
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT03624244 on ClinicalTrials.govOther trials for Endometrial stromal sarcoma
Additional recruiting or active studies for the same condition.